When it comes to diagnosing glaucoma, the role of the optometrist is growing, however, ophthalmologists overwhelmingly continue to be the providers initiating glaucoma treatment, according to a study.
Between 2007 to 2018, 303,440 patients received initial glaucoma care by ophthalmologists and 98,1…
Welcome to the Ophthalmic Project—a series of blogs and podcasts written and produced by Mark L. Dlugoss, senior contributing editor. The Ophthalmic Project will address trends, events, and observations in the world of ophthalmology. Dlugoss has about 25 years of experience…
When it comes to diagnosing glaucoma, the role of the optometrist is growing, however, ophthalmologists overwhelmingly continue to be the providers initiating glaucoma treatment, according to a study.
Between…
The first of two Phase 3 studies evaluating NOV03 (perfluorohexyloctane; Bausch + Lomb) as a first-in-class investigational drug to treat the signs and symptoms of Dry eye disease (DED) associated with Meibomian gland dysfunction (MGD) has been completely enrolled with a total of 599…